Sven Thormahlen

68 year

Consumer Non-Durables

Health Technology

Consumer Services

Profile

Dr. Sven Thormahlen is Chief Technology Officer at Corbion NV.
He is on the Board of Directors at Accera, Inc. Dr. Thormahlen was previously employed as Executive Vice President-Research & Development by Danone SA, Chief Executive Officer by MucoVax GmbH, Outside Director by Yakult Honsha Co., Ltd., and Senior Vice President-Research & Development by L'Oréal SA. He received his graduate degree from the University of Hamburg and a doctorate degree from the University of Hamburg.

Former positions of Sven Thormahlen

Companies	Position	End
MucoVax GmbH	Chief Executive Officer	-
CORBION N.V.	Chief Tech/Sci/R&D Officer	-
L'ORÉAL	Chief Tech/Sci/R&D Officer	-
Cerecin, Inc. Cerecin, Inc. Pharmaceuticals: MajorHealth Technology Cerecin, Inc. develops therapies to treat central nervous system disorders. It offers therapeutic treatments for Parkinson's disease, Alzheimer's disease, and other age-related memory loss disorders. The firm is also developing therapies that address metabolic deficiencies and provide an alternative energy source for brain cells. The company was founded in 2001 and is headquartered in Boulder, CO.	Director/Board Member	-
YAKULT HONSHA CO.,LTD.	Director/Board Member	-

See the detail of Sven Thormahlen's experience

Training of Sven Thormahlen

University of Hamburg

Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies